A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

[1]  M. Donia,et al.  Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model , 2017, Nature Communications.

[2]  A. Hauschild,et al.  Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. , 2017, European journal of cancer.

[3]  Rameen Beroukhim,et al.  Patient-derived xenografts undergo murine-specific tumor evolution , 2017, Nature Genetics.

[4]  Y. Kallberg,et al.  Validation and development of MTH1 inhibitors for treatment of cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  C. Jiang,et al.  Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588. , 2016, The Journal of investigative dermatology.

[6]  Alexey Sergushichev,et al.  An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation , 2016 .

[7]  Makoto Muroi,et al.  Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival , 2016, Scientific Reports.

[8]  Michael C. Rusch,et al.  Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation , 2016, Scientific Reports.

[9]  A Mayakonda,et al.  Maftools: Efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies , 2016, bioRxiv.

[10]  Graeme Walker,et al.  Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival. , 2016, Journal of medicinal chemistry.

[11]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[12]  Joshua M. Korn,et al.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response , 2015, Nature Medicine.

[13]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[14]  Jonathan M. Mudge,et al.  Creating reference gene annotation for the mouse C57BL6/J genome assembly , 2015, Mammalian Genome.

[15]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[16]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[17]  Richard D Emes,et al.  Detailed comparison of two popular variant calling packages for exome and targeted exon studies , 2014, PeerJ.

[18]  Marcela Dávila López,et al.  Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions , 2014, Oncotarget.

[19]  D. Nguyen,et al.  MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways , 2014, Oncogene.

[20]  J. Taube,et al.  Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy , 2014, Clinical Cancer Research.

[21]  Richard Svensson,et al.  MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool , 2014, Nature.

[22]  Yan Mei,et al.  The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA , 2014, Genome Biology.

[23]  F. Kiessling,et al.  Multidrug resistance: Physiological principles and nanomedical solutions. , 2013, Advanced drug delivery reviews.

[24]  Z. Binkhathlan,et al.  P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.

[25]  Josep Malvehy,et al.  Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. , 2012, European journal of cancer.

[26]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[27]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[28]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[29]  J. Wilmott,et al.  Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma , 2011, Clinical Cancer Research.

[30]  R. Weinberg,et al.  Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence , 2011, Oncogene.

[31]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[32]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[33]  Loic Hamon,et al.  Role of Microtubules in Stress Granule Assembly , 2009, The Journal of Biological Chemistry.

[34]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[35]  R. Weinberg,et al.  Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence , 2009, Proceedings of the National Academy of Sciences.

[36]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Cole,et al.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.

[38]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[39]  I. Pastan,et al.  A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[41]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[42]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..